{"result": "(\"entity\"<|>GENES DE SUSCEPTIBILIDAD<|>ORGANIZATION<|>Genes of susceptibility are genetic factors that increase the risk of developing pheochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>SDHB<|>ORGANIZATION<|>SDHB is a gene associated with succinate dehydrogenase and is linked to familial pheochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>SDHD<|>ORGANIZATION<|>SDHD is a gene that encodes a subunit of succinate dehydrogenase and is implicated in hereditary pheochromocytomas and paragangliomas.)\n##\n(\"entity\"<|>SDHAF2<|>ORGANIZATION<|>SDHAF2 is a gene that encodes a factor involved in the assembly of succinate dehydrogenase and is associated with certain tumors.)\n##\n(\"entity\"<|>CARCINOMA RENAL<|>EVENT<|>Renal carcinoma is a type of kidney cancer that can occur in patients with Von Hippel-Lindau disease.)\n##\n(\"relationship\"<|>GENES DE SUSCEPTIBILIDAD<|>SDHB<|>SDHB is one of the susceptibility genes linked to the development of pheochromocytomas and paragangliomas<|>8)\n##\n(\"relationship\"<|>GENES DE SUSCEPTIBILIDAD<|>SDHD<|>SDHD is another susceptibility gene associated with familial pheochromocytomas and paragangliomas<|>8)\n##\n(\"relationship\"<|>GENES DE SUSCEPTIBILIDAD<|>SDHAF2<|>SDHAF2 is a susceptibility gene that has been described in a few patients with pheochromocytomas<|>6)\n##\n(\"relationship\"<|>VON HIPPEL-LINDAU<|>CARCINOMA RENAL<|>Carcinoma renal is a common manifestation in patients with Von Hippel-Lindau disease<|>7)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ponible en:\n           of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.                                                                 https://manual.seen.es (última modificación: 24 de noviembre de 2015).\n         • Young WF, Jr, Kebebew E. Treatment of pheochromocytoma in adults. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.      • Lenders JWM, Duh QY, Eisenhofer G, Gimenez-Roqueplo AP, Grebe SKG, Murad MH, et al. Pheochromocytoma and paraganglioma:\n           com. Literature review current through: Apr. 2019.                                                                                  an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2014;99:1915-41.\n                                                                                                                                             • Neumann HPH. Feocromocitoma. En: Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscazo J, eds. Harrison Principios\n                                                                                                                                               de Medicina Interna. 19.ª edición en español. México DF: Mc Graw Hill; 2016. p. 2329-35.\n                                                                                                                                             • Young WF, Jr. Clinical presentation and diagnosis of pheochromocytoma. UpToDate. Waltham, MA: UpToDate Inc. https://www.\n     29  Respecto a las mutaciones en los genes de la succinato deshidrogenasa (SDH),                                                          uptodate.com. Literature review current through: Apr. 2019.\n                                                                                                                                             • Young WF, Jr. Endocrine Hypertension. En: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams Textbook\n         es cierto que:                                                                                                                        of Endocrinology. 13.ª ed. Philadelphia: Elsevier; 2016. p. 556-88.\n                                                                                                                                             • Young WF, Jr, Kebebew E. Treatment of pheochromocytoma in adults. UpToDate. Waltham, MA: UpToDate Inc. https://www.uptodate.\n         A. Los genes de la SDH se consideran supresores tumorales.                                                                            com. Literature review current through: Apr. 2019.\n         B. Un 5-10% de los paragangliomas familiares son causados por mutaciones en estos\n             genes.                                                                                                                          ¿Cuál de las siguientes alteraciones no se da en la enfermedad de Von Hippel-\n         C. La mayoría de estas mutaciones se producen en el gen SDHAF2, que codifica un factor                                          30  Lindau (VHL)?\n             de ensamblaje.\n         D. Las mutaciones de sentido               erróneo (missense) son las más               comunes, excepto                            A. Hipotiroidismo.\n             en el SDHD.                                                                                                                     B. Hemangioblastomas cerebelosos.\n                                                                                                                                             C. Carcinoma renal.\n         COMENTARIO                                                                                                                          D.  Feocromocitoma.\n         Hasta el momento actual se han descrito 15 genes de susceptibilidad para el desarrollo de\n         los feocromocitomas y paragangliomas.                                                                                               COMENTARIO\n         La gran mayoría (70% a 80%) de las mutaciones germinales detectadas en los genes de                                                 La enfermedad de Von Hippel-Lindau es un trastorno autosómico dominante caracteri-\n         susceptibilidad para feocromocitoma y paraganglioma se localizan en SDHB, SDHD y gen                                                zado por la presencia de feocromocitomas (con frecuencia bilateral), paragangliomas, an-\n         de VHL. Las mutaciones en SDHA y SDHAF2 han sido descritas en pocos pacientes.                                                      giomas retinianos, hemagioblastomas cerebelosos, cistoadenoma de epidídimo, quistes\n         La mayoría de los casos de paraganglioma familiar están causados por mutaciones en                                                  pancreáticos y renales y carcinoma renal.\n         subunidades de genes (SDHB, SDHC y SDHD) de la succinato deshidrogenasa (SDH), que                                                  El feocromocitoma se produce en alrededor del 10-20% de los pacientes con enfermedad\n         forman fragmentos del complejo mitocondrial II. El complejo mitocondrial II es un gen su-                                           de Von Hippel-Lindau. La prevalencia del síndrome es de 1 de cada 35.000 personas.\n         presor tumoral que interviene en la cadena de transporte de electrones y en el ciclo del                                            El gen supresor tumoral VHL, localizado en el cromosoma 3p25-26, codifica una proteína\n         ácido tricarboxílico (ATC). La mayoría de los casos de paragangioma familiar se asocian a                                           que regula proteínas inducidas por hipoxia. Casi el 100% de los pacientes presentan una\n         mutaciones en estos genes.                                                                                                          mutación identificable y existe correlación genotipo-fenotipo. Hasta en un 98% de casos, el\n\n\n\n284                                                                                                                                                                                                                                                                           285\n---\n                                                                                                                                                                                                                         SUPRARRENALES                                        5\n\n\n\n               feocrom\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>UPTODATE INC.<|>ORGANIZATION<|>UpToDate Inc. is a medical resource providing clinical information and guidelines for healthcare professionals.)\n##\n(\"entity\"<|>YOUNG WF, JR.<|>PERSON<|>Young WF, Jr. is a medical professional known for his work on pheochromocytoma and related endocrine disorders.)\n##\n(\"entity\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>ORGANIZATION<|>Harrison's Principles of Internal Medicine is a comprehensive medical textbook covering various aspects of internal medicine.)\n##\n(\"entity\"<|>ENDOCRINE SOCIETY<|>ORGANIZATION<|>The Endocrine Society is a professional organization dedicated to advancing the field of endocrinology and providing clinical practice guidelines.)\n##\n(\"entity\"<|>VON HIPPEL-LINDAU<|>EVENT<|>Von Hippel-Lindau disease is an autosomal dominant disorder characterized by the presence of pheochromocytomas, among other tumors.)\n##\n(\"entity\"<|>SUCCINATE DEHYDROGENASE<|>ORGANIZATION<|>Succinic dehydrogenase is an enzyme complex involved in the mitochondrial respiratory chain and is associated with tumor suppression.)\n##\n(\"entity\"<|>FEOCROMOCITOMA<|>EVENT<|>Pheochromocytoma is a tumor of the adrenal gland that can cause excessive production of catecholamines.)\n##\n(\"entity\"<|>PARAGANGLIOMA<|>EVENT<|>Paraganglioma is a type of tumor that arises from the paraganglia, which are neuroendocrine tissues associated with the autonomic nervous system.)\n##\n(\"relationship\"<|>YOUNG WF, JR.<|>UPTODATE INC.<|>Young WF, Jr. contributes to UpToDate Inc. with clinical presentations and treatment guidelines for pheochromocytoma<|>8)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>YOUNG WF, JR.<|>Young WF, Jr. is involved with the Endocrine Society, which publishes clinical practice guidelines on pheochromocytoma<|>7)\n##\n(\"relationship\"<|>HARRISON PRINCIPIOS DE MEDICINA INTERNA<|>YOUNG WF, JR.<|>Young WF, Jr. is referenced in Harrison's Principles of Internal Medicine for his expertise in pheochromocytoma<|>6)\n##\n(\"relationship\"<|>SUCCINATE DEHYDROGENASE<|>FEOCROMOCITOMA<|>Mutations in succinate dehydrogenase genes are linked to the development of pheochromocytomas<|>9)\n##\n(\"relationship\"<|>VON HIPPEL-LINDAU<|>FEOCROMOCITOMA<|>Pheochromocytoma occurs in a significant percentage of patients with Von Hippel-Lindau disease<|>8)\n##\n(\"relationship\"<|>VON HIPPEL-LINDAU<|>PARAGANGLIOMA<|>Von Hippel-Lindau disease is associated with the development of paragangliomas<|>7)\n##\n(\"relationship\"<|>ENDOCRINE SOCIETY<|>SUCCINATE DEHYDROGENASE<|>The Endocrine Society provides guidelines related to genetic mutations in succinate dehydrogenase affecting pheochromocytoma<|>6)\n<|COMPLETE|>"}]}